塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/04/23 | 6,353 | 6,406 | 6,337 | 6,387 | +88 | +1.4% | 920,800 |
2019/04/22 | 6,280 | 6,346 | 6,228 | 6,299 | -30 | -0.5% | 724,500 |
2019/04/19 | 6,350 | 6,360 | 6,278 | 6,329 | -94 | -1.5% | 1,387,700 |
2019/04/18 | 6,600 | 6,632 | 6,409 | 6,423 | -200 | -3% | 1,491,900 |
2019/04/17 | 6,615 | 6,646 | 6,544 | 6,623 | +8 | +0.1% | 1,227,500 |
2019/04/16 | 6,521 | 6,658 | 6,493 | 6,615 | +94 | +1.4% | 1,514,800 |
2019/04/15 | 6,580 | 6,590 | 6,483 | 6,521 | -62 | -0.9% | 1,293,700 |
2019/04/12 | 6,645 | 6,647 | 6,531 | 6,583 | +37 | +0.6% | 1,568,700 |
2019/04/11 | 6,484 | 6,575 | 6,463 | 6,546 | +96 | +1.5% | 1,263,400 |
2019/04/10 | 6,479 | 6,533 | 6,404 | 6,450 | -93 | -1.4% | 902,300 |
2019/04/09 | 6,500 | 6,554 | 6,435 | 6,543 | -26 | -0.4% | 1,201,300 |
2019/04/08 | 6,592 | 6,596 | 6,503 | 6,569 | -23 | -0.3% | 772,200 |
2019/04/05 | 6,573 | 6,634 | 6,540 | 6,592 | -31 | -0.5% | 972,800 |
2019/04/04 | 6,787 | 6,794 | 6,606 | 6,623 | -153 | -2.3% | 1,119,700 |
2019/04/03 | 6,838 | 6,842 | 6,710 | 6,776 | -19 | -0.3% | 1,053,300 |
2019/04/02 | 6,905 | 6,913 | 6,780 | 6,795 | -57 | -0.8% | 880,200 |
2019/04/01 | 6,969 | 6,990 | 6,817 | 6,852 | ±0 | ±0% | 1,178,100 |
2019/03/29 | 6,770 | 6,859 | 6,770 | 6,852 | +135 | +2% | 1,058,800 |
2019/03/28 | 6,714 | 6,768 | 6,627 | 6,717 | -191 | -2.8% | 2,331,200 |
2019/03/27 | 6,830 | 6,917 | 6,813 | 6,908 | +167 | +2.5% | 1,532,300 |
2019/03/26 | 6,600 | 6,768 | 6,552 | 6,741 | +293 | +4.5% | 1,568,400 |
2019/03/25 | 6,605 | 6,637 | 6,428 | 6,448 | -236 | -3.5% | 1,286,700 |
2019/03/22 | 6,860 | 6,860 | 6,651 | 6,684 | -153 | -2.2% | 1,443,300 |
2019/03/20 | 6,796 | 6,845 | 6,775 | 6,837 | -22 | -0.3% | 1,126,900 |
2019/03/19 | 6,841 | 6,860 | 6,777 | 6,859 | +22 | +0.3% | 599,800 |
2019/03/18 | 6,830 | 6,855 | 6,791 | 6,837 | +20 | +0.3% | 651,700 |
2019/03/15 | 6,727 | 6,838 | 6,722 | 6,817 | +110 | +1.6% | 1,136,800 |
2019/03/14 | 6,800 | 6,817 | 6,701 | 6,707 | -8 | -0.1% | 1,004,700 |
2019/03/13 | 6,650 | 6,720 | 6,650 | 6,715 | -4 | -0.1% | 1,037,100 |
2019/03/12 | 6,756 | 6,770 | 6,705 | 6,719 | +43 | +0.6% | 1,053,800 |
2019/03/11 | 6,648 | 6,735 | 6,648 | 6,676 | +28 | +0.4% | 896,500 |
2019/03/08 | 6,744 | 6,771 | 6,641 | 6,648 | -144 | -2.1% | 1,826,300 |
2019/03/07 | 6,829 | 6,882 | 6,789 | 6,792 | -65 | -0.9% | 1,278,400 |
2019/03/06 | 6,938 | 6,963 | 6,831 | 6,857 | -143 | -2% | 1,655,900 |
2019/03/05 | 6,972 | 7,019 | 6,949 | 7,000 | -32 | -0.5% | 1,295,700 |
2019/03/04 | 7,160 | 7,169 | 7,010 | 7,032 | -63 | -0.9% | 1,424,200 |
2019/03/01 | 7,075 | 7,145 | 7,070 | 7,095 | -21 | -0.3% | 788,900 |
2019/02/28 | 7,177 | 7,200 | 7,097 | 7,116 | -61 | -0.8% | 1,085,800 |
2019/02/27 | 7,140 | 7,177 | 7,084 | 7,177 | +64 | +0.9% | 1,365,200 |
2019/02/26 | 7,072 | 7,161 | 7,064 | 7,113 | -8 | -0.1% | 844,800 |
2019/02/25 | 7,064 | 7,121 | 7,025 | 7,121 | +107 | +1.5% | 986,500 |
2019/02/22 | 7,046 | 7,072 | 6,987 | 7,014 | +2 | ±0% | 855,600 |
2019/02/21 | 7,017 | 7,070 | 6,938 | 7,012 | +16 | +0.2% | 1,011,400 |
2019/02/20 | 6,962 | 7,043 | 6,958 | 6,996 | +30 | +0.4% | 1,062,600 |
2019/02/19 | 6,933 | 6,999 | 6,880 | 6,966 | +12 | +0.2% | 873,900 |
2019/02/18 | 6,849 | 6,992 | 6,849 | 6,954 | +105 | +1.5% | 1,081,300 |
2019/02/15 | 6,724 | 6,849 | 6,723 | 6,849 | +125 | +1.9% | 1,284,400 |
2019/02/14 | 6,699 | 6,766 | 6,682 | 6,724 | +15 | +0.2% | 900,800 |
2019/02/13 | 6,751 | 6,770 | 6,698 | 6,709 | -47 | -0.7% | 979,400 |
2019/02/12 | 6,519 | 6,763 | 6,515 | 6,756 | +304 | +4.7% | 1,370,200 |
1551~
1600
件表示中 / 3773件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 255,000円 | +20.9% | +10.6% | 2.59% | 12.06倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 776,600円 | +2.2% | +28.0% | 1.80% | 12.43倍 | 1.51倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 162,000円 | +0.9% | +380.2% | 4.81% | 22.32倍 | 1.92倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 254,500円 | -3.5% | -11.3% | 2.36% | 23.37倍 | 1.58倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 453,800円 | +0.1% | -3.4% | 3.53% | 30.85倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム